Genomic Health to Announce Fourth Quarter and Year End 2007 Financial Results and Host Conference Call on Tuesday, February 5, 2008

Thursday, January 31, 2008 General News J E 4
REDWOOD CITY, Calif., Jan. 30 Genomic Health,Inc. (Nasdaq: GHDX) today announced that the company will host a conferencecall and webcast on Tuesday, February 5, 2008 at 4:30 p.m. Eastern Time todiscuss its fourth quarter and year end 2007 financial results. The call andwebcast will follow the release of the fourth quarter financial results aftermarket close.

Conference Call Details

To access the live conference call via phone, please dial (877) 356-8064from the United States and Canada or (706) 758-4314 internationally. Theconference ID is 33305336. Please dial in approximately ten minutes prior tothe start of the call. A telephone replay will be available beginningapproximately one hour after the call through February 12 and may be accessedby dialing (800) 642-1687 from the United States and Canada or (706) 645-9291internationally. The replay passcode is 33305336.

To access the live and subsequently archived webcast of the conferencecall, go to the Investor Relations section of the company's website at Please connect to the web site at least 15minutes prior to the call to allow for any software download that may benecessary.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused onthe development and commercialization of genomic-based clinical laboratoryservices for cancer that allow physicians and patients to make individualizedtreatment decisions. In 2004, Genomic Health launched its first test service,Oncotype DX(R), which has been shown to predict the likelihood of breastcancer recurrence and the likelihood of chemotherapy benefit in a largeportion of early-stage breast cancer patients. The company was founded in 2000and is located in Redwood City, California. For more information, please visit

NOTE: Genomic Health, the Genomic Health logo, Oncotype, Oncotype DX andRecurrence Score are trademarks or registered trademarks of Genomic Health,Inc. All other trademarks and service marks are the property of theirrespective owners.Contacts: Brad Cole Genomic Health, Inc. 650-569-2281 Media: Emily Faucette Genomic Health 650-569-2824

SOURCE Genomic Health, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Milestone Scientific Names Joseph D'Agostino as Ac...
Nuvelo Initiates Phase 1 Clinical Trial of Thrombi...